In addition, since PPARG plays a critical role in the mechanism of action by which bacillus Calmette-Guérin (BCG) inhibits bladder tumor growth [22,23], the decreased level of amplification of the third sample could be explained thanks to the BCG treatment after the second TURB. Here, PPARG is linked to urinary bladder neoplasm.